Strategic Prevention Framework for Prescription Drugs (SPF-Rx)

Forms and Documents

Document Name	Status
Form Grantee-Level Inte Grantee-Level Interview Form and Instruction	New
Form Annual Implementat Annual Implementation Instrument Form and Instruction	New
Form Community-Level Ou Community-Level Outcomes Form and Instruction	New
Form Grantee-Level Outc Grantee-Level Outcomes Module Form and Instruction	New
Form Evaluation Plan Evaluation Plan Form and Instruction	Removed
Form Grantee-Level Inte Grantee-Level Interview Form and Instruction	Removed
Form Annual Implementat Annual Implementation Instrument Form and Instruction	Removed
Form Substitue Data Req Substitue Data Request Form Form and Instruction	Removed
Form Community-Level Ou Community-Level Outcomes Module Form and Instruction	Removed
Form Grantee-Level Outc Grantee-Level Outcomes Module Form and Instruction	Removed
SPF-Rx OMB Supporting Statement_A_5.12.2020.docx Supporting Statement A	2020-05-12
Attachment 5_SPF-Rx Summary of Changes to the OMB Pkg_11.21.2019.docx Supplementary Document	2020-05-11
SPF-Rx OMB Supporting Statement_B_11.21.2019.docx Supporting Statement B	2020-05-06

IC Document Collections

IC ID	Document Title	Status
241788	Grantee-Level Interview Form and Instruction	New
241787	Annual Implementation Instrument Form and Instruction	New
241773	Community-Level Outcomes Form and Instruction	New
241772	Grantee-Level Outcomes Module Form and Instruction	New
227233	Evaluation Plan Form and Instruction	Removed
227232	Grantee-Level Interview Form and Instruction	Removed
227231	Annual Implementation Instrument Form and Instruction	Removed
227230	Substitue Data Request Form Form and Instruction	Removed
227229	Community-Level Outcomes Module Form and Instruction	Removed
227224	Grantee-Level Outcomes Module Form and Instruction	Removed

ICR Details

OMB Control No: 0930-0377	ICR Reference No: 202005-0930-001
Status: Received in OIRA	Previous ICR Reference No: 201706-0930-003
Agency/Subagency: HHS/SAMHSA	Agency Tracking No:
Title: Strategic Prevention Framework for Prescription Drugs (SPF-Rx)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 05/13/2020

	Requested	Previously Approved
Expiration Date	36 Months From Approved	01/31/2021
Responses	321	204
Time Burden (Hours)	1,869	618
Cost Burden (Dollars)	0	0

---

Abstract: The SPF-Rx program is designed to address nonmedical use of prescription drugs as well as opioid overdoses by raising awareness about the dangers of sharing medications and by working with pharmaceutical and medical communities. The SPF-Rx program aims to promote collaboration between states/tribes and pharmaceutical and medical communities to understand the risks of overprescribing to youth age 12–17 and adults 18 years of age and older and enhance capacity for and access to Prescription Drug Monitoring Program (PDMP) data for prevention purposes.

---

Authorizing Statute(s): US Code: 42 USC 516 Name of Law: Healthy Pople 2020 Substance Abuse Yopic Area HP 2020-SA
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 10455	02/24/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 27756	05/11/2020
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 4

IC Title	Form No.	Form Name
Grantee-Level Outcomes Module	Grantee-Level Outcomes	Grantee-Level Outcomes
Grantee-Level Outcomes Module	Grantee-Level Outcomes	Grantee-Level Outcomes
Annual Implementation Instrument	Annual Implementation Instrument	Annual Implementation Instrument
Community-Level Outcomes	Community-Level Outcomes	Community-Level Outcomes
Community-Level Outcomes Module	Community-Level Outcomes	Community-Level Outcomes
Substitue Data Request Form	Substitue Data Request Form	Substitue Data Request Form
Annual Implementation Instrument	Annual Implementation Instrument	Annual Implementation Instrument
Grantee-Level Interview	Grantee-Level Interview	Grantee-Level Interview
Grantee-Level Interview	Grantee-Level Interview	Grantee-Level Interview
Evaluation Plan	Evaluation Plan	Evaluation Plan

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	321	204	0	321	-204	0
Annual Time Burden (Hours)	1,869	618	0	1,869	-618	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Currently, there are 618 total burden hours. SAMHSA is requesting 1,867.5 burden hours. This is an adjustment of 1,249.5 hours based on actual burden estimates revisions to data collection instruments. This equates to an overall increase of 1,249.5 hours and $15,504.06 over the previously approved data collection.The annual burden costs have increased from previous approval due to 4 factors: 1. The previous OMB approval estimated 100 AII responses (25 grantees and 75 subrecipients), but the SPF-Rx grantees currently have 25 grantees and 123 subrecipients, totaling 148 AII responses, accounting for an additional 48 responses, 192 hours and $4,974.72 per year of data collection with the entire grantee cohort (i.e., Years 4 and 5). 2. The previous OMB approval estimated only 25 Community-Level Outcomes Module responses, but one is completed for each subrecipient, and therefore the burden has been increased to 123 responses, accounting for an additional 98 responses, 343 hours, and $14,961.66 per year of data collection with the entire grantee cohort (i.e., Years 4 and 5). 3. Based on grantee feedback, the time it takes for respondents to complete the AII was increased from 2.3 hours to 4 hours. While grantee feedback indicated that the Grantee-Level Outcomes Module burden should be increased from 3 hours to 6.2 hours, the module was reduced and the burden decreased to 2.5 hours. The Community-Level Outcomes Module burden was initially increased from 3 hours to 3.5 hours based on grantee feedback, but the instrument was subsequently reduced and the burden now estimated at 1.25 hours. The adjustments in the three instruments results in an overall reduction of 55 hours and $2,248.4 per year of data collection with the entire grantee cohort (i.e., Years 4 and 5). This reflects a 42% decrease in burden for the Grantee-Level Outcomes and the Community-Level Outcomes Modules (decrease from 6 hours to 3.75 hours across all respondents in all years). We expect that these burden estimates are more accurate than previous burden estimates, given that they are based on feedback from those who have completed data collection efforts during Years 1 and 2 of the evaluation in addition to changes in the data collection instruments based on the identification of duplicative data elements. 4. The SPF-Rx hourly wage estimates in the previous statement were $40.88, based on one salary using 2015 Bureau of Labor Statistics (BLS) data. The current package increased grantee-level staff to 2018 BLS data for hourly wages of $43.62. BLS data are an accurate representation of salary data, utilizing the National Compensation Survey which provides comprehensive measures of compensation cost trends and is updated each year to reflect those changes in average compensation.

---

Annual Cost to Federal Government: $1,651,992

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 05/13/2020

---